Women cured of childhood leukaemia should be advised to have children while they are young

July 03, 2002

Vienna, Austria: Women who have survived having leukaemia as children should receive fertility counselling because their reproductive life may be shortened even though they have an apparently normal menstrual cycle after treatment, according to Danish researchers.

Dr Elisabeth Larsen, a research assistant from the Fertility Clinic at Copenhagen University Hospital, Denmark, has studied 26 long-term survivors of acute lymphoblastic leukaemia (ALL) and found that they tended to have smaller ovaries with fewer follicles (the group of cells containing the female egg) available in each menstrual cycle. However, the good news was that their ovaries appeared to be functioning normally in all other respects, she told the annual conference of the European Society of Human Reproduction and Embryology.

She said: "Multi-agent chemotherapy has radically increased long-term survival of children with acute lymphoblastic leukaemia, but the treatment can induce late effects. It is well known that a proportion of the patients experience ovarian failure and infertility. The new finding is that female childhood cancer survivors with an apparently normal menstrual cycle might have a shortened reproductive span."

Dr Larsen and her team took menstrual and pregnancy histories from 26 women* who had received standard chemotherapy for ALL contracted between the ages of six months and fourteen and a half years, and compared them with a control group of 20 women with no history of childhood cancer. Eight of the women in the ALL group had become pregnant naturally, resulting in 12 babies, one abortion and two ongoing pregnancies. One woman, aged 33, had tried to become pregnant without success for five years, but many of the women were young and 17 of the 26 had not even tried to conceive yet. All the women had regular menstrual cycles and normal hormonal levels, although the length of the cycle in the ALL group was significantly shorter than in the control group (28.9 versus 30.7 days).

The researchers used transvaginal ultrasounds, taken at the beginning of the menstrual cycle, to measure the volume of the women's ovaries and to count the number of antral follicles (follicles that may mature and subsequently ovulate). They found that women in the ALL group had ovaries which were significantly smaller than the control group (12.3 ml in total volume compared with 13.7ml), and the total number of antral follicles per ovary was significantly lower in the ALL women, with an average of eight per ovary compared with 11 in the control group.

Dr Larsen said: "Although these long-term survivors of childhood leukaemia have an apparently normal ovarian function, our results suggest that the chemotherapy has reduced the numbers of follicles in the ovaries. Therefore it is important that women who have survived childhood leukaemia should receive careful and individual fertility counselling as their reproductive life may be shortened."

She said that it was not possible to give a precise estimate of how much shorter the women's reproductive life might be. "At present, in our hospital, we recommend to all female survivors of childhood cancer with normal ovarian function that they should try to have their first child before they are 30. However this recommendation is not made on the basis of any scientific findings. The majority of long-term survivors attend regular follow-up check-ups at our outpatient clinic and we are considering offering fertility counselling to them between the ages of 18 and 20.

"The important message to come from this research is women who have survived ALL can become pregnant and have babies and they are doing so. However they should not postpone childbearing, and it might be that they should consider becoming mothers before pursuing a career," concluded Dr Larsen.
Abstract no: 0-228 (Wednesday 11.00hrs CET Hall E2) URL: http://conf.eshre.com/PDF/O-228.pdf

* Childhood cancer is relatively rare with approximately 150 new cases diagnosed each year in Denmark. Fifty per cent are treated at Dr Larsen's hospital, and of these 35 will be girls and about 25-35% of these girls will have ALL.

Further information:
Margaret Willson, information officer
Tel: +44 (0) 1536 772181
Mobile: +44 (0) 7973 853347
Fax: +44 (0) 1536 772191
Email: m.willson@mwcommunications.org.uk

Emma Mason, information officer
Tel: +44 (0) 1376 563090
Fax: +44 (0) 1376 563272
Mobile: +44 (0)7711 296986
Email: wordmason@aol.com

Press Office: (Sunday 30 June -Wednesday 3 July)
Margaret Willson, Emma Mason, Janet Blümli
Tel: +43 (0) 1 260 69 2010 or
+43 (0) 1 260 69 2011
Fax: +43 (0) 1 260 69 2012

European Society of Human Reproduction and Embryology

Related Childhood Cancer Articles from Brightsurf:

Anti-depressant repurposed to treat childhood cancer
A new study has found that a commonly prescribed anti-depressant may halt growth of a type of cancer known as childhood sarcoma, at least in mice and laboratory cell experiments.

Promising treatment for aggressive childhood cancer
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer.

Suicidality among adult survivors of childhood cancer
A recent study found that survivors of childhood cancer have a similar risk of having suicidal thoughts compared with other individuals, and they have lower risk of suicidal behaviors and suicidal death.

Monitoring for breast cancer after childhood chest radiation: When and how?
Girls who receive chest radiation for cancer are at risk for future breast cancers.

Geography of childhood cancer in Switzerland studied
A research group under the direction of the Institute of Social and Preventive Medicine of the University Bern has investigated the spatial distribution of childhood cancer risks in Switzerland for the period 1985-2015.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Scientists discover a new mechanism in childhood kidney cancer
A problem in reader proteins that identify which gene is up for expression may cause normal cells to turn malignant during development.

Root of childhood kidney cancer discovered
A fundamental change in our understanding of the childhood kidney cancer Wilms' tumor is on the horizon, after the discovery of its earliest genetic root by scientists at the Wellcome Sanger Institute and their collaborators.

Breakthrough in understanding common childhood cancer
Scientists studying one of the most common forms of childhood cancer have made an important breakthrough in understanding how the disease progresses.

Researchers find new way to target childhood cancer
An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma, by uncovering a new and as-yet unexploited target in cancer cells that therapeutic drugs can be aimed at.

Read More: Childhood Cancer News and Childhood Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.